Related Experiment Video
Updated: Jul 29, 2026
05:49
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Delusional misidentification and platelet monoamine oxidase
Biological Psychiatry
|April 1, 1980
Summary
Reduced platelet monoamine oxidase (MAO) activity was observed in a patient with the Delusion of Doubles, a disorder involving false recognition. This finding suggests a potential link between MAO enzyme activity and delusional states.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Capgras' syndrome, a delusion of doubles, has been associated with altered neurobiological markers.
- Previous studies indicated reduced platelet monoamine oxidase (MAO) activity in paranoid schizophrenia with Capgras' syndrome.
Observation:
- This study investigated platelet monoamine oxidase (MAO) activity in an additional patient presenting with the Delusion of Doubles.
- The patient exhibited delusional hyperidentification, a form of false recognition.
Findings:
- Decreased platelet monoamine oxidase (MAO) activity was detected in the patient compared to normal controls.
- Despite not having schizophrenia, the patient's MAO activity levels were comparable to those observed in chronic schizophrenic patients.
Implications:
- The findings suggest a potential role for reduced monoamine oxidase (MAO) activity in the pathophysiology of delusional disorders like the Delusion of Doubles.
- This could indicate shared neurobiological mechanisms between certain delusional states and schizophrenia.
- Further research is warranted to explore the significance of MAO activity in delusional hyperidentification and related psychiatric conditions.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...